A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
Public ClinicalTrials.gov record NCT05995353. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multi-Center Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Risankizumab With Open-Label Induction, Randomized Double-Blind Maintenance, and Long-Term Extension Periods in Pediatric Subjects (2 to < 18 Years of Age) With Moderately to Severely Active Crohn's Disease
Study identification
- NCT ID
- NCT05995353
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- AbbVie
- Industry
- Enrollment
- 110 participants
Conditions and interventions
Conditions
Interventions
- Risankizumab Drug
Drug
Eligibility (public fields only)
- Age range
- 2 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 10, 2023
- Primary completion
- Mar 31, 2029
- Completion
- Mar 31, 2029
- Last update posted
- May 12, 2026
2023 – 2029
United States locations
- U.S. sites
- 11
- U.S. states
- 11
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Phoenix Children's Hospital /ID# 255766 | Phoenix | Arizona | 85016-7710 | Recruiting |
| Arkansas Children's Hospital /ID# 255762 | Little Rock | Arkansas | 72202 | Recruiting |
| UCSF Benioff Children's Hospital - Oakland /ID# 258327 | Oakland | California | 94609 | Recruiting |
| Children's Hospital Colorado - Aurora /ID# 255764 | Aurora | Colorado | 80045 | Recruiting |
| Arnold Palmer Hospital for Children Center Digestive Health & Nutrition - Orland /ID# 255437 | Orlando | Florida | 32806-1141 | Recruiting |
| Indiana University Health Riley Hospital for Children /ID# 256454 | Indianapolis | Indiana | 46202 | Recruiting |
| Massachusetts General Hospital /ID# 255767 | Boston | Massachusetts | 02114 | Recruiting |
| MNGI Digestive Health, P. A. /ID# 255366 | Minneapolis | Minnesota | 55413-2195 | Recruiting |
| Goryeb Childrens Hospital /ID# 256452 | Morristown | New Jersey | 07960 | Recruiting |
| Icahn School of Medicine at Mount Sinai /ID# 254880 | New York | New York | 10029 | Recruiting |
| Cleveland Clinic - Cleveland /ID# 256453 | Cleveland | Ohio | 44195 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 74 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05995353, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 12, 2026 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05995353 live on ClinicalTrials.gov.